| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
| mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.01 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
| mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
| mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.04 |